Arnaud Bourdin

15.6k total citations · 4 hit papers
288 papers, 6.9k citations indexed

About

Arnaud Bourdin is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Arnaud Bourdin has authored 288 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 185 papers in Pulmonary and Respiratory Medicine, 150 papers in Physiology and 48 papers in Surgery. Recurrent topics in Arnaud Bourdin's work include Asthma and respiratory diseases (127 papers), Respiratory and Cough-Related Research (65 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (51 papers). Arnaud Bourdin is often cited by papers focused on Asthma and respiratory diseases (127 papers), Respiratory and Cough-Related Research (65 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (51 papers). Arnaud Bourdin collaborates with scholars based in France, United States and United Kingdom. Arnaud Bourdin's co-authors include Pascal Chanez, Isabelle Vachier, Sandhia Ponnarambil, Andrew Menzies‐Gow, Fabrice Paganin, Delphine Gras, Peter Barker, Njira Lugogo, Marc Humbert and Parameswaran Nair and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Arnaud Bourdin

253 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma

2017 716 citations Parameswaran Nair, Arnaud Bourdin et al. New England Journal of Medicine profile →
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma

2021 606 citations Andrew Menzies‐Gow, Arnaud Bourdin et al. New England Journal of Medicine profile →
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

2017 441 citations Athénaïs Boucly, Laurent Savale et al. profile →
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis

2024 69 citations Michael E. Wechsler, Parameswaran Nair et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Arnaud Bourdin

Since Specialization

Citations

This map shows the geographic impact of Arnaud Bourdin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnaud Bourdin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnaud Bourdin more than expected).

Fields of papers citing papers by Arnaud Bourdin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnaud Bourdin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnaud Bourdin. The network helps show where Arnaud Bourdin may publish in the future.

Co-authorship network of co-authors of Arnaud Bourdin

This figure shows the co-authorship network connecting the top 25 collaborators of Arnaud Bourdin. A scholar is included among the top collaborators of Arnaud Bourdin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnaud Bourdin. Arnaud Bourdin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mepolizumab reduced healthcare resource utilization and improved work productivity in patients with severe asthma during the REALITI-A 2-year study 2025 ·Journal of Asthma ·Giorgio Walter Canonica, Arnaud Bourdin, Erika Penz, Lingjiao Zhang, Peter Howarth, (unknown)	0
2	Dupilumab Improves Lung Function, Asthma Control and Exacerbation Frequency in Allergic Bronchopulmonary Aspergillosis – Results from the Phase 2 LIBERTY ABPA AIRED Study 2025 ·American Journal of Respiratory and Critical Care Medicine ·Arnaud Bourdin, (unknown), Anand Shah, Caroline Baxter, (unknown), Nikhil Amin, (unknown), (unknown), Andrew P. Fontenot, Paula Dakin, Elizabeth Laws, Jennifer Maloney, (unknown), Allen Radin	2
3	Added value of technician intervention to improve mask management for apneic patients treated with long-term CPAP 2025 ·Sleep And Breathing ·(unknown), (unknown), Jean‐Pierre Mallet, (unknown), Jean‐Christian Borel, Frédéric Gagnadoux, Sarah Skinner, Arnaud Bourdin, Nicolas Molinari, Dany Jaffuel	0
4	Precision medicine targeting groups of intervention in difficult-to-treat asthma 2024 ·SPIRE - Sciences Po Institutional REpository ·Pascal Demoly, Anne‐Sophie Gamez, Arnaud Bourdin, Davide Caimmi	0
5	Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-Asthma Biologics 2024 ·The Journal of Allergy and Clinical Immunology In Practice ·Arnaud Bourdin, Guy Brusselle, Simon Couillard, Merritt L. Fajt, Liam G. Heaney, Elliot Israel, P. Jane McDowell, Andrew Menzies‐Gow, Neil Martin, Patrick Mitchell, Nayia Petousi, Santiago Quirce, Florence Schleich, Ian Pavord	24
6	MELTEMI and COLUMBA: 5-Year Comparative Safety Analysis of Benralizumab and Mepolizumab 2024 ·The Journal of Allergy and Clinical Immunology In Practice ·Arnaud Bourdin, Geoffrey Chupp, (unknown), (unknown), (unknown), (unknown), (unknown), Andrew Menzies‐Gow	5
7	What is the true target population for biologics in real-life COPD or asthma-COPD overlap patients? 2024 ·BMJ Open Respiratory Research ·M. Zysman, (unknown), (unknown), Camille Taillé, Jésus Gonzalez‐Bermejo, (unknown), (unknown), Arthur Pavot, Pierre‐Olivier Girodet, Arnaud Bourdin, Nicolas Molinari, Patrick Berger	2
8	EFFICACY OF BENRALIZUMAB AND MEPOLIZUMAB ON ASTHMA OUTCOMES IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 2024 ·Annals of Allergy Asthma & Immunology ·(unknown), Arnaud Bourdin, Pascal Chanez, David J. Jackson, Shahid Siddiqui, U. Specks, (unknown), (unknown)	1
9	Longitudinal patterns of intermittent oral corticosteroid therapy for asthma in the United Kingdom 2024 ·SHILAP Revista de lepidopterología ·Trung N. Tran, (unknown), Jennifer Rowell, Jeffrey Shi Kai Chan, Arnaud Bourdin, (unknown), Benjamin Emmanuel, (unknown), D.J. Jackson, Andrew Menzies‐Gow, Ruth Murray, Derek Skinner, David Price	1
10	Outcomes and risk assessment in pulmonary veno-occlusive disease 2024 ·ERJ Open Research ·Athénaïs Boucly, (unknown), Antoine Beurnier, Xavier Jaïs, (unknown), Mélanie Eyries, Andrei Seferian, Mitja Jevnikar, Anne Roche, Sophie Bulifon, Arnaud Bourdin, Ari Chaouat, Vincent Cottin, Laurent Bertoletti, Laurent Savale, Marc Humbert, Olivier Sitbon, David Montani	7
11	Altered skeletal muscle function and beneficial effects of exercise training in a rat model of induced pulmonary emphysema 2024 ·Acta Physiologica ·Emilie Passerieux, (unknown), (unknown), (unknown), (unknown), Anne Virsolvy, Farès Gouzi, Olivier Cazorla, Arnaud Bourdin, Maurice Hayot, Pascal Pomiès	1
12	Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis breakdown → 2024 ·New England Journal of Medicine ·Michael E. Wechsler, Parameswaran Nair, Benjamin Terrier, (unknown), Arnaud Bourdin, David Jayne, David J. Jackson, Florence Roufosse, (unknown), Ying Fan, Maria Jison, Christopher McCrae, Sofia Necander, Anat Shavit, (unknown), Peter A. Merkel	69
13	Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017–2022: An Analysis of the International Severe Asthma Registry 2024 ·Journal of Asthma and Allergy ·Tham Le, David Price, (unknown), Bill Cook, (unknown), Rohit Katial, George Christoff, Luis Pérez de Llano, Alan Altraja, Céline Bergeron, Arnaud Bourdin, (unknown), Lauri Lehtimäki, Bassam Mahboub, Nikolaos G. Papadopoulos, Paul Pfeffer, Chin Kook Rhee, Victoria Carter, Neil Martin, Trung N. Tran	5
14	Sputum-Rheology-Based Strategy for Guiding Azithromycin Prescription in COPD Patients with Frequent Exacerbations: A Randomized, Controlled Study (“COPD CARhE”) 2023 ·Biomedicines ·Jérémy Charriot, M. Zysman, Laurent Guilleminault, (unknown), A. Petit, Isabelle Vachier, (unknown), Carey Suehs, Engi Ahmed, Nicolas Molinari, Arnaud Bourdin	2
15	Elevated Blood Pressure Occurs without Endothelial Dysfunction in a Rat Model of Pulmonary Emphysema 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Patrice Bideaux, (unknown), (unknown), Arnaud Bourdin, Olivier Cazorla, Farès Gouzi, Anne Virsolvy	3
16	Diastolic Cardiomyopathy Secondary to Experimentally Induced Exacerbated Emphysema 2023 ·American Journal of Respiratory Cell and Molecular Biology ·(unknown), (unknown), (unknown), Farès Gouzi, Patrice Bideaux, (unknown), Valérie Scheuermann, Alain Lacampagne, Anne Virsolvy, Jérôme Thireau, Pieter P. de Tombe, Arnaud Bourdin, Olivier Cazorla	4
17	Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studies 2022 ·Therapeutic Advances in Respiratory Disease ·Thomas B. Casale, (unknown), Arnaud Bourdin, Peter Howarth, Beth Hahn, (unknown), Sandhya Khurana	10
18	Anti-interleukin 5 therapies failure criteria in severe asthma: a Delphi-consensus study 2021 ·Therapeutic Advances in Respiratory Disease ·(unknown), Carey Suehs, Khuder Alagha, Arnaud Bourdin, (unknown), Jérémy Charriot, Gilles Devouassoux, Stéphanie Fry, Laurent Guilleminault, M. Gouitaa, Camille Taillé, Pascal Chanez, Laurie Pahus	2
19	Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019 2020 ·The Journal of Infectious Diseases ·Anne‐Sophie Bedin, Alain Makinson, Marie‐Christine Picot, (unknown), Fabrice Malergue, Amandine Pisoni, (unknown), (unknown), Karine Bolloré, (unknown), David Morquin, (unknown), (unknown), (unknown), (unknown), Caroline Bret, Arnaud Bourdin, (unknown), Philippe Van de Perre, Édouard Tuaillon	43
20	Efficacy of Whole-Lung Lavage in Pulmonary Alveolar Proteinosis: A Multicenter International Study of GELF 2017 ·Respiration ·(unknown), B. Wallaert, (unknown), Jonas Yserbyt, Stavros Anevlavis, C. Hermant, Alban Lovis, Olivier Ménard, Bernard Maître, (unknown), Hervé Dutau, Amandine Briault, Arnaud Bourdin, Jean‐Michel Vergnon, Μarios E. Froudarakis, (unknown)	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact